These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 25961450)

  • 1. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
    Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
    Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of T cell signaling in systemic lupus erythematosus.
    Moulton VR; Tsokos GC
    Arthritis Res Ther; 2011 Mar; 13(2):207. PubMed ID: 21457530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dysregulation of cytokine networks in systemic lupus erythematosus.
    Apostolidis SA; Lieberman LA; Kis-Toth K; Crispín JC; Tsokos GC
    J Interferon Cytokine Res; 2011 Oct; 31(10):769-79. PubMed ID: 21877904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
    Katsuyama T; Tsokos GC; Moulton VR
    Front Immunol; 2018; 9():1088. PubMed ID: 29868033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell transcription factors: Potential new therapeutic targets for SLE.
    De S; Barnes BJ
    Clin Immunol; 2014; 152(1-2):140-51. PubMed ID: 24674882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells as a therapeutic target in SLE.
    Comte D; Karampetsou MP; Tsokos GC
    Lupus; 2015 Apr; 24(4-5):351-63. PubMed ID: 25801878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant B cell selection and activation in systemic lupus erythematosus.
    Kil LP; Hendriks RW
    Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
    Singh RR; Ebling FM; Sercarz EE; Hahn BH
    J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell abnormalities in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
    Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus and T cells.
    La Cava A
    Lupus; 2009 Mar; 18(3):196-201. PubMed ID: 19213856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.
    Jacob N; Stohl W
    Autoimmunity; 2010 Feb; 43(1):84-97. PubMed ID: 20014977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell abnormalities in systemic lupus erythematosus.
    Nagy G; Koncz A; Perl A
    Crit Rev Immunol; 2005; 25(2):123-40. PubMed ID: 15952933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2005 Sep; 17(5):523-8. PubMed ID: 16093828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinations of B cell fate in immunity and autoimmunity.
    Noelle RJ; Erickson LD
    Curr Dir Autoimmun; 2005; 8():1-24. PubMed ID: 15564715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.